Procter & Gamble Co (NYSE:PG) is Puzo Michael J’s 6th Largest Position

Share on StockTwits

Puzo Michael J lessened its holdings in shares of Procter & Gamble Co (NYSE:PG) by 4.8% in the 4th quarter, Holdings Channel reports. The fund owned 79,457 shares of the company’s stock after selling 3,978 shares during the quarter. Procter & Gamble accounts for 3.6% of Puzo Michael J’s holdings, making the stock its 6th largest holding. Puzo Michael J’s holdings in Procter & Gamble were worth $9,922,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Lucia Wealth Services LLC acquired a new position in Procter & Gamble in the third quarter valued at approximately $29,000. Belmont Capital LLC purchased a new position in Procter & Gamble in the fourth quarter worth approximately $34,000. Selective Wealth Management Inc. acquired a new stake in Procter & Gamble during the third quarter worth $35,000. Princeton Global Asset Management LLC increased its stake in Procter & Gamble by 51.4% during the second quarter. Princeton Global Asset Management LLC now owns 442 shares of the company’s stock worth $48,000 after acquiring an additional 150 shares during the last quarter. Finally, Ironwood Financial llc increased its stake in Procter & Gamble by 27.3% during the third quarter. Ironwood Financial llc now owns 480 shares of the company’s stock worth $60,000 after acquiring an additional 103 shares during the last quarter. Institutional investors own 62.74% of the company’s stock.

Shares of NYSE PG opened at $125.96 on Thursday. The company has a current ratio of 0.72, a quick ratio of 0.54 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $310.95 billion, a PE ratio of 27.87, a PEG ratio of 3.38 and a beta of 0.40. Procter & Gamble Co has a twelve month low of $89.08 and a twelve month high of $126.60. The stock has a fifty day simple moving average of $124.20 and a 200-day simple moving average of $120.41.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, October 22nd. The company reported $1.37 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.13. Procter & Gamble had a return on equity of 25.07% and a net margin of 6.24%. The firm had revenue of $17.80 billion for the quarter, compared to analyst estimates of $17.43 billion. During the same quarter in the prior year, the company earned $1.12 EPS. Procter & Gamble’s revenue was up 6.6% on a year-over-year basis. On average, equities analysts predict that Procter & Gamble Co will post 4.94 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be paid a dividend of $0.7459 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.98 dividend on an annualized basis and a yield of 2.37%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.93%.

A number of research firms have recently weighed in on PG. TheStreet upgraded Procter & Gamble from a “c+” rating to a “b+” rating in a report on Tuesday, October 22nd. Wells Fargo & Co increased their price target on Procter & Gamble from $135.00 to $136.00 and gave the stock an “outperform” rating in a report on Wednesday, October 23rd. Macquarie raised their price objective on Procter & Gamble from $132.00 to $138.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 23rd. JPMorgan Chase & Co. boosted their price objective on shares of Procter & Gamble from $136.00 to $139.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Finally, UBS Group upped their target price on shares of Procter & Gamble from $122.00 to $126.00 and gave the company a “neutral” rating in a research report on Wednesday, October 23rd. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $119.07.

In related news, CEO Ma. Fatima Francisco sold 1,729 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $122.00, for a total transaction of $210,938.00. Following the completion of the transaction, the chief executive officer now directly owns 6,856 shares of the company’s stock, valued at approximately $836,432. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO David S. Taylor sold 50,000 shares of the business’s stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $124.01, for a total value of $6,200,500.00. Following the transaction, the chief executive officer now directly owns 277,521 shares of the company’s stock, valued at $34,415,379.21. The disclosure for this sale can be found here. Insiders have sold 1,288,513 shares of company stock worth $159,734,252 over the last quarter. Insiders own 1.75% of the company’s stock.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Read More: Treasury Bonds

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.